To evaluate safety and diagnostic accuracy of gadoteridol vs. other macrocyclic gadolinium-based contrast agents (GBCAs) in a large cohort of consecutive and non-selected patients referred for CE-MRI of the CNS.
Diagnostic efficacy and safety of gadoteridol compared to gadobutrol and gadoteric acid in a large sample of CNS MRI studies at 1.5T / Del Poggio, Anna; Anello, Giulia; Calloni, Sonia Francesca; Vezzulli, Paolo; Pereira, Clodoaldo; Iadanza, Antonella; Falini, Andrea; Anzalone, Nicoletta. - In: JOURNAL OF NEURORADIOLOGY. - ISSN 0150-9861. - 49:1(2022), pp. 73-79. [10.1016/j.neurad.2020.06.005]
Diagnostic efficacy and safety of gadoteridol compared to gadobutrol and gadoteric acid in a large sample of CNS MRI studies at 1.5T
Falini, AndreaPenultimo
Writing – Review & Editing
;Anzalone, Nicoletta
Ultimo
Conceptualization
2022-01-01
Abstract
To evaluate safety and diagnostic accuracy of gadoteridol vs. other macrocyclic gadolinium-based contrast agents (GBCAs) in a large cohort of consecutive and non-selected patients referred for CE-MRI of the CNS.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
